RNA-Driven Chromatin Shredding Targets Cancer Mutations
TL;DR Summary
Researchers engineered an RNA-guided CRISPR-Cas12a2 nuclease to recognize cancer-specific transcripts and trigger transcript-activated chromatin shredding, leading to DNA damage responses and selective death of cancer cells in experimental systems, offering a potential precision approach to targeting undruggable mutations such as p53.
- Targeting Cancer-Specific Mutations with RNA-Triggered Chromatin Shredding Nature
- Could cave bacteria help cure cancer? A USU discovery suggests they might Utah Public Radio
- CRISPR Shreds Undruggable Cancer Cells with Precision Genetic Engineering and Biotechnology News
- RNA-Triggered Chromatin Shredding Targets Cancer Mutations Bioengineer.org
- Breakthroughs in CRISPR technology on Access Utah Utah Public Radio
Reading Insights
Total Reads
0
Unique Readers
5
Time Saved
12 min
vs 13 min read
Condensed
98%
2,416 → 41 words
Want the full story? Read the original article
Read on Nature